Evidence map›Paper›PMID 28001368›Full record

ArticleBiochemistry2017

Biochemical Validation of a Second Guanidine Riboswitch Class in Bacteria.

Madeline E Sherlock, Sarah N Malkowski, Ronald R Breaker

Open access · greenAbstract readValidation Study
In one paragraph

Article in Biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Review
  3. Deciphering guanidine assimilation and riboswitch-based gene regulation in cyanobacteria for synthetic biology applications.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Biomolecular NMR assignments · 2025
    Article
  9. ACS chemical biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. The current riboswitch landscape inMicrobiology (Reading, England) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Discovering riboswitches: the past and the future.Trends in biochemical sciences · 2023
    Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Madeline E SherlockDepartment of Molecular Biophysics and Biochemistry, ‡Department of Chemistry, §Department of Molecular, Cellular and Developmental Biology, and ∥Howard Hughes Medical Institute, Yale University , New Haven, Connecticut 06520, United States.ORCID http://orcid.org/0000-0002-6471-4243
Sarah N MalkowskiDepartment of Molecular Biophysics and Biochemistry, ‡Department of Chemistry, §Department of Molecular, Cellular and Developmental Biology, and ∥Howard Hughes Medical Institute, Yale University , New Haven, Connecticut 06520, United States.ORCID http://orcid.org/0000-0002-9644-6917
Ronald R BreakerDepartment of Molecular Biophysics and Biochemistry, ‡Department of Chemistry, §Department of Molecular, Cellular and Developmental Biology, and ∥Howard Hughes Medical Institute, Yale University , New Haven, Connecticut 06520, United States.
Howard Hughes Medical Institute · US

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
X-RAY ANALYSIS OF PROTEIN STRUCTURE AND FUNCTIONP01GM022778 · NIGMS · YALE UNIVERSITY · PI BREAKER, RONALD R · 1985 to 2019
$26.1M
Investigating Mechanisms of Fluoride Sensing and Toxicity Mitigation in BacteriaR01DE022340 · NIDCR · YALE UNIVERSITY · PI BREAKER, RONALD R · 2012 to 2015
$1.5M
Natural mRNA Genetic Switches that Bind MetabolitesR01GM068819 · NIGMS · YALE UNIVERSITY · PI BREAKER, RONALD R · 2003 to 2006
$1.3M
NIDCR NIH HHS R01 DE022340NIGMS NIH HHS P01 GM022778NIGMS NIH HHS R01 GM068819NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

Recently, it was determined that representatives of the riboswitch candidates called ykkC and ykkC-III directly bind free guanidine. Guanidine-binding ykkC motif RNAs, now renamed guanidine-I riboswitches, were demonstrated to commonly regulate the expression of genes encoding guanidine carboxylases, as well as others encoding guanidine efflux proteins such as EmrE and SugE. Likewise, genes encoding similar efflux proteins are associated with ykkC-III motif RNAs, which have now been renamed guanidine-III riboswitches. Prior to the validation of guanidine as the ligand for these newly established riboswitch classes, another RNA motif was discovered by comparative genomic analysis and termed mini-ykkC because of its small size and gene associations similar to those of the original ykkC motif. It was hypothesized that these distinct RNA structures might respond to the same ligand. However, the small size and repetitive nature of mini-ykkC RNAs suggested that it might respond to ligand via the action of a protein factor. Herein, we demonstrate that, despite its extremely simple architecture, mini-ykkC motif RNAs constitute a distinct class of guanidine-sensing RNAs, called guanidine-II riboswitches. Surprisingly, each of the two stem-loop structures that comprise the mini-ykkC motif appears to directly bind free guanidine in a cooperative manner. These findings reveal that bacteria make extensive use of diverse guanidine-responsive riboswitches to overcome the toxic effects of this compound.

Indexed as

Gene Expression Regulation, BacterialRiboswitchAntiportersAptamers, NucleotideComputational BiologyCyanobacteriaEscherichia coliEscherichia coli ProteinsGuanidinesKlebsiella pneumoniaeLigandsNucleic Acid ConformationRNA, BacterialAntiportersAptamers, NucleotideEmrE protein, E coliEscherichia coli ProteinsGuanidinesLigandsRiboswitchRNA, Bacterial

Identifiers

PMID28001368
PMCPMC5340285
OpenAlexW2564944183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.